JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2876
AngioDynamics
ANGO
$635M
| $5.53M | ﹤0.01% |
705,522
+113,707
| +19% | +$789K |
2016 Q1
31 quarters
|
|
2877
Atlantic Union Bankshares
AUB
$5.54B
| $5.52M | ﹤0.01% |
150,986
-39,972
| -21% | -$1.26M |
2013 Q2
42 quarters
|
|
2878
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.66B
| $5.52M | ﹤0.01% |
+200,000
| New | +$4.35M |
2023 Q4
0 quarters
|
|
2879
Mirum Pharmaceuticals
MIRM
$5.38B
| $5.51M | ﹤0.01% |
186,583
+86,807
| +87% | +$2.63M |
2019 Q3
17 quarters
|
|
2880
PUT
NetApp
NTAP
$44.4B
| $5.5M | ﹤0.01% |
62,400
+2,200
| +4% | +$177K |
2021 Q3
9 quarters
|
|
2881
CALL
Rocket Pharmaceuticals
RCKT
$281M
| $5.5M | ﹤0.01% |
+183,400
| New | +$4.05M |
2023 Q4
0 quarters
|
|
2882
TransAlta
TAC
$3.91B
| $5.49M | ﹤0.01% |
660,953
+326,833
| +98% | +$2.64M |
2014 Q3
37 quarters
|
|
2883
Trinity Industries
TRN
$2.08B
| $5.48M | ﹤0.01% |
206,181
+43,391
| +27% | +$1.04M |
2013 Q2
42 quarters
|
|
2884
Capital Group Growth ETF
CGGR
$26.1B
| $5.48M | ﹤0.01% |
+194,171
| New | +$5.02M |
2023 Q4
0 quarters
|
|
2885
Vanguard Long-Term Bond ETF
BLV
$5.42B
| $5.48M | ﹤0.01% |
73,450
+205
| +0.3% | +$14K |
2021 Q1
11 quarters
|
|
2886
Invesco S&P 500 Revenue ETF
RWL
$9.72B
| $5.48M | ﹤0.01% |
64,182
+9,473
| +17% | +$760K |
2021 Q1
11 quarters
|
|
2887
PUT
CONMED
CNMD
$1.39B
| $5.48M | ﹤0.01% |
50,000
-20,000
| -29% | -$2.07M |
2023 Q3
1 quarter
|
|
2888
CALL
Voya Financial
VOYA
$8.76B
| $5.47M | ﹤0.01% |
+75,000
| New | +$5.23M |
2023 Q4
0 quarters
|
|
|
2889
PUT
Voya Financial
VOYA
$8.76B
| $5.47M | ﹤0.01% |
+75,000
| New | +$5.23M |
2023 Q4
0 quarters
|
|
2890
State Street SPDR S&P Health Care Equipment ETF
XHE
$189M
| $5.46M | ﹤0.01% |
64,783
+30,979
| +92% | +$2.31M |
2017 Q2
26 quarters
|
|
2891
JetBlue
JBLU
$1.57B
| $5.46M | ﹤0.01% |
983,351
+570,346
| +138% | +$2.67M |
2014 Q3
37 quarters
|
|
2892
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.82B
| $5.45M | ﹤0.01% |
108,196
+54,957
| +103% | +$2.77M |
2020 Q1
15 quarters
|
|
2893
PUT
BHP
BHP
$219B
| $5.43M | ﹤0.01% |
79,500
+65,000
| +448% | +$3.92M |
2023 Q1
3 quarters
|
|
|
JPUS
2894
JPMorgan Diversified Return US Equity ETF
JPUS
$453M
| $5.42M | ﹤0.01% |
52,779
-4,395
| -8% | -$423K |
2015 Q4
32 quarters
|
|
|
SLAM
2895
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $5.42M | ﹤0.01% |
+499,995
| New | +$5.42M |
2023 Q4
0 quarters
|
|
2896
Metallus
MTUS
$824M
| $5.41M | ﹤0.01% |
230,780
+69,857
| +43% | +$1.47M |
2017 Q4
24 quarters
|
|
|
ELME
2897
Elme Communities
ELME
$156M
| $5.41M | ﹤0.01% |
370,595
+99,549
| +37% | +$1.36M |
2013 Q2
42 quarters
|
|
2898
Warby Parker
WRBY
$3.34B
| $5.41M | ﹤0.01% |
383,576
+249,841
| +187% | +$3.11M |
2021 Q3
9 quarters
|
|
2899
CALL
Dollar General
DG
$26.2B
| $5.4M | ﹤0.01% |
39,700
-57,600
| -59% | -$6.99M |
2021 Q3
9 quarters
|
|
|
RCM
2900
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.39M | ﹤0.01% |
510,272
+45,892
| +10% | +$520K |
2017 Q4
24 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.